Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 24 Nov 2025 16:40 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 24 Nov 2025 07:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Quarterly Report Q3 2025 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 13 Nov 2025 08:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – Invitation to Q3 2025 Financial Results Presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 05 Nov 2025 07:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics to Present Data on the Strength of the Neoantigen Selection Method from Two Clinical Trials at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 04 Nov 2025 07:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Strengthens Intellectual Property Portfolio with New U.S. Patent for the Neoantigen Selection Method for VB10.NEO, Nykode’s Individualized Neoantigen Therapy | 20103010 Biotechnology | Non-regulatory press releases |
| 14 Oct 2025 08:17 CEST |
NYKODE THERAPEUTICS ASA | Disclosure of Large Shareholding - Nykode Therapeutics ASA | 20103010 Biotechnology | Major shareholding notifications |
| 10 Oct 2025 17:44 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – Grant of Share Options | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Oct 2025 14:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Oct 2025 12:36 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 09 Oct 2025 20:27 CEST |
NYKODE THERAPEUTICS ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Aug 2025 07:01 CEST |
NYKODE THERAPEUTICS ASA | Nykode Announces Updated Strategy to Increase Value for Patients and Shareholders, Prioritizing VB10.16 as the Lead Value Driver | 20103010 Biotechnology | Inside information |
| 27 Aug 2025 07:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Quarterly report Q2 2025 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 20 Aug 2025 08:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – Invitation to Q2 2025 Financial Results Presentation and Strategy Update | 20103010 Biotechnology | Non-regulatory press releases |
| 09 Jul 2025 18:15 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – Grant of Share Options | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 04 Jul 2025 16:41 CEST |
NYKODE THERAPEUTICS ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 May 2025 07:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Quarterly report Q1 2025 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 27 May 2025 07:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA - Ex-dividend NOK 1.00 today | 20103010 Biotechnology | Ex Date |
| 26 May 2025 16:51 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – invitation to Q1 2025 financial results presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 26 May 2025 11:25 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA - Minutes of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 May 2025 07:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Highlights New Data in Two Poster Presentations at the 2025 ASCO Annual Meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 05 May 2025 08:30 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA - Notice of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Apr 2025 07:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Annual Report 2024 | 20103010 Biotechnology | Annual financial and audit Reports |
| 28 Apr 2025 19:17 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – Key information relating to proposed cash dividend | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Apr 2025 15:50 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA - Minutes of Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Apr 2025 07:20 CEST |
NYKODE THERAPEUTICS ASA | Nykode announces that Michael Engsig, CEO; Agnete Fredriksen, CSO & Co-founder; and Harald Gurvin, CFO; have withdrawn their recent resignations and continue with Nykode; proposal of new Board members; potential dividend of NOK 1.00 per share | 20103010 Biotechnology | Inside information |
| 11 Apr 2025 18:59 CEST |
NYKODE THERAPEUTICS ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Apr 2025 09:40 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA - Notice of Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Mar 2025 16:56 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 27 Mar 2025 14:15 CET |
NYKODE THERAPEUTICS ASA | OSLO BØRS – TRADING RESUMPTION | 20103010 Biotechnology | Trading halts |
| 27 Mar 2025 13:33 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – resignation of Chair of the Board, Board Members, Chief Executive Officer, Chief Scientific Officer and Chief Financial Officer | 20103010 Biotechnology | Inside information |
| 27 Mar 2025 13:30 CET |
NYKODE THERAPEUTICS ASA | OSLO BØRS - TRADING SUSPENSION | 20103010 Biotechnology | Trading halts |
| 27 Feb 2025 20:30 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Announces Preclinical Data Highlighting its Immune Tolerance Platform’s Ability to Modulate Multiple Key Immune Components in Autoimmune Disease | 20103010 Biotechnology | Non-regulatory press releases |
| 26 Feb 2025 07:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Quarterly report Q4 2024 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 14 Feb 2025 16:05 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – invitation to Q4 2024 financial results presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Jan 2025 10:50 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Announces Publication of Phase 2 VB-C-02 Data Confirming Prolonged Benefit and Definitive Vaccination Effects | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Dec 2024 19:47 CET |
NYKODE THERAPEUTICS ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Dec 2024 13:35 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Streamlining Board of Directors | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Dec 2024 14:19 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Mandatory Notification of Trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 04 Dec 2024 19:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Presents New Data on Individualized Cancer Immunotherapy at the Personalized Cancer Vaccines Summit | 20103010 Biotechnology | Non-regulatory press releases |
| 27 Nov 2024 00:05 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Quarterly report Q3 2024 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 20 Nov 2024 18:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – invitation to Q3 2024 financial results presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Nov 2024 15:18 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 08 Nov 2024 15:10 CET |
NYKODE THERAPEUTICS ASA | Disclosure of large shareholding in Nykode Therapeutics ASA | 20103010 Biotechnology | Major shareholding notifications |
| 08 Nov 2024 00:15 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – Webcast Invitation | 20103010 Biotechnology | Non-regulatory press releases |
| 07 Nov 2024 23:25 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics to Regain Control of VB10.NEO Program | 20103010 Biotechnology | Inside information |
| 06 Nov 2024 17:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at PEGS Europe | 20103010 Biotechnology | Non-regulatory press releases |
| 27 Sep 2024 08:11 CEST |
NYKODE THERAPEUTICS ASA | Major shareholding notification | 20103010 Biotechnology | Major shareholding notifications |
| 21 Aug 2024 16:20 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 21 Aug 2024 07:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Quarterly report Q2 2024 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 21 Aug 2024 06:30 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Announces Strategic Repositioning of VB10.16 to Focus on Locally Advanced Cervical Cancer and Recurrent Metastatic Head and Neck Cancer | 20103010 Biotechnology | Inside information |